Radiopharm Theranostics RADX
NASDAQ RADX
$0.88 -0.07 (-7.70%)
At close: Nov 9, 2026 · 4:00 PM EST

Radiopharm Theranostics (RADX) Current Assets (2024 - 2026)

Updated

Radiopharm Theranostics' Current Assets was $155,531 in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 39.1% from $255,238 a year earlier.

Analysis

Radiopharm Theranostics (RADX) Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2026 (ended Jun 30, 2026), Current Assets at Radiopharm Theranostics came in at $148,911, down 99.6% from FY2025.

  • In earlier fiscal years, Current Assets was $39.85 million in FY2025 (+74.4%) and $22.85 million in FY2024.
  • The fiscal Q4 2026 figure marks the lowest quarterly Current Assets since fiscal Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 65.26 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 56.35 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 37.48 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 38.94 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 31.45 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 34.36 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 16.55 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 45.01 Bn
10 Radiopharm Theranostics 2.70 Bn 2.62 Bn - 21.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.93 Mn
Jun 30, 2025 39.85 Mn
Dec 31, 2024 44.35 Mn
Jun 30, 2024 22.85 Mn
API Access

Radiopharm Theranostics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=RADX&period=max&api_key=YOUR_API_KEY